NFKB1 and atherosclerosis: CD14 is a pro-inflammatory cytokine that activates NF-κB and MAPK pathways and importantly has been linked to the development of arterial wall inflammation seen in atherosclerosis[41], a process which is also similarly seen in the spiral arteries of patients with PE.